Pieter Wyckmans and Michiel D’herde teamed up to write this year’s Belgian chapter of the Global Legal Insight’s Pricing and Reimbursement series.
This article reflects on the pharmaceutical pricing and reimbursement procedure in Belgium and discusses the major impact COVID-19 has in this area.
The article has been published in Pricing & Reimbursement 2020 by Global Legal Group Ltd, London. Read the full publication on www.globallegalinsights.com
Website